Our Vision
Provide hope where none existed before
Our Mission
Develop plasmalogen derivatives that transform the lives of patients with rare pediatric neurological disorders and neurodegenerative diseases
EXECUTIVE LEADERSHIP
Dr. T. Fujino, MD, PhD Founder
Professor Emeritus, Kyushu University, Japan
CEO, Institute of Rheological Functions of Food
Director, BOOCS Medical Group
Founder, International Plasmalogen Society & Japanese Plasmalogen Society
Eunhee Ohgami, PhD CEO
She was previously the CSO at a prestigious Japanese medical group for over 12 years and the COO at a biotech start-up developing Dementia Treatments.
Global head of clinical development from 2015 to 2022, helping global biotech companies enter the Japanese and US market.
700+ clinical study experience in the CNS area.
Christopher Aleong, Chief Strategy Officer
Christopher has over twenty-five years of global experience in the pharma and biotech sectors. In past years with Bayer, Abbott and Sanofi, he held executive roles in general management, sales & marketing, commercial operations, finance and human resources.
Executive expertise in commercialization of innovation, strategic and operational reviews, market analysis, business development assessments, organizational transformations and growth, customer engagement and business partnerships in developed and emerging markets.
Bruce Smith, CFO
Top-performing senior financial executive with an entrepreneurial spirit and strong record of providing people, processes, and systems necessary for rapid growth and global expansion in fast-paced, competitive industries.
Proven ability to reduce costs, improve efficiencies, build robust relationships with other departments, attract and develop top talent, manage internal and external resources, and improve accounting policies and procedures. Skilled at leveraging systems to improve business effectiveness.
Scientific Advisors
Kelly Austin, PhD, PPM
She is a regulatory specialist, especially in orphan and rare disease drug development.
She has supported 300+ FDA and 100+ EMA Orphan drug submissions and 100+ Fast Track, Breakthrough, and RMAT submissions.
Deborah Hartman, PhD
Scientist and senior leader with international experience in pharmaceutical research and a proven track record of advancing drug candidates through discovery and early clinical development in CNS areas.
Previously, she was Chief Scientific Officer in 3 medium biotech companies and Vice President and global program leader of a multinational pharmaceutical company.
Deborah Lee, MD, PhD
She is an MD specializing in Pediatric neurology, peripheral neuropathies, and Alzheimer’s disease. She has extensive drug development experience as a senior medical director at several multinational pharmaceutical companies.
Scientific Advisory Board
Shiro Mawatari MD, PhD
Director, Institute of Rheological Functions of Food
At the Institute of Rheological Functions of Food, he has developed new measurement and extraction techniques for lipids and other substances, and is engaged in the extraction and development of functional substances from food materials using these techniques. As part of these efforts, he has. developed a method for mass extraction and simple measurement of plasmalogen and discovered new polyphenols.
PhD in Medicine, Kyushu University, Japan
- 1971 Research Assistant, School of Medicine, Kyushu University
- 1972 Research Fellow, Department of Neurology, University of Pennsylvania (biochemical studies of erythrocyte membranes in dystrophy)
- 1973 Research Fellow, Neurological Institute, Columbia University, (biochemical studies of erythrocyte membranes in dystrophy)
- 1976 Associate Professor, Kyushu Institute of Technology
- 1981 Deputy Director, National Chikugo Hospital
- 1989 Director, Health Management Center, NTT Fukuoka
- 1994 Professor, Faculty of Human Environment, Fukuoka Women’s University
- 2005 Director, Institute of Rheological Functions of Food
Shamim Hossain PhD
Director of Basic Research, Institute of Rheological Functions of Food
His experience in molecular biology has led him to study neuroinflammation, memory dysfunction, diabetes, pathogenic susceptibility, cancer, and more related to aging.
MPharmSci, Rajshahi University, Bangladesh
Phd in Medicine, Chiba University, Japan (research on novel proto-oncogenes and neuroscience)
- 2003 Lecturer, Department of Pharmacy, Rajshahi University
- 2009 Researcher, Chiba Cancer Center Research Institute
- 2012 Associate Professor, School of Medicine, Kyushu University (physiology and neuroscience)
- 2016 Associate Professor / Principal Investigator, School of Medicine, Kyushu University
- 2020 Research Director, Institute of Rheological Functions of Food (age-related physiological changes: neuroinflammation, memory impairment, intestinal bacterial sac symbiosis, metabolic syndrome, immune dysfunction, NK cells, macrophages)
Tatsuo Okauchi PhD
Professor, Department of Applied Chemistry, Faculty of Engineering, Kyushu Institute of Technology
PhD in Science, The University of Tokyo
- 1992 Synthesis Researcher, Eisai Tsukuba Research Laboratories (Development of Novel Anticancer Drugs)
- 1995 Research Assistant, Department of Applied Chemistry, Faculty of Engineering, Kyushu Institute of Technology (Development of catalytic asymmetric synthetic reactions using optically active phosphorus ligands)
- 1999 Lecturer, Department of Applied Chemistry, Faculty of Engineering, Kyushu Institute of Technology (Development of organic synthetic reactions using metal- olefin complexes)
- 2002 Associate Professor, Department of Applied Chemistry, Faculty of Engineering, Kyushu Institute of Technology (Synthesis of bioactive compounds with phosphorus atom, Development of new synthetic methods for phosphate esters, Synthesis of bioactive compounds with phosphorus atoms)
- 2024 Professor, Department of Applied Chemistry, Faculty of Engineering, Kyushu Institute of Technology
Masanori Honsho PhD
Professor, Department of Neuroinflammation and Brain Fatigue Science, Graduate School of Medicine, Kyushu University
PhD in Science, Kyushu University
- 1997 Japan Science and Technology Corp. (Research on cell organellogenesis)
- 1998 Ph.D. in Science
- 2001 Max-Planck Institute of Molecular Cell Biology and Genetics
- 2003 Associate Professor, Graduate School of Systems Life Science, Kyushu University (Research on peroxisome biosynthesis)
- 2008 Associate Professor,
Graduate School of Science, Kyushu University (Research on cell fate determination and its disruption) - 2010 Associate Professor, Graduate School of Science, Kyushu University (Research on regulation of ether phospholipid biosynthesis)
- 2015 Associate Professor, Medical Institute of Bioregulation, Kyushu University
- 2019 Director of Basic Research, Institute of Rheological Functions of Food (Research on novel physiological functions of ether phospholipids)
- 2020 Associate Professor, Graduate School of Medicine, Kyushu University (Research on homeostasis mechanisms and novel physiological functions of ether phospholipids)
- 2023 Professor, Graduate School of Medicine, Kyushu University
How We Work
Everything we do at NeuroCores is based on:
Putting patients first
being a great place to work
honoring our core values
We are committed to conducting our business with integrity and the pursuit of excellence. Our Management Team and our Board of Directors are committed to honesty and compliance with all laws, rules, and regulations that apply to our business.
Our Core Values
Compassion & Care
We are driven by a deep compassion for children and their families affected by devastating rare pediatric neurological conditions. Providing hope through transformative therapies is at the heart of our mission.
Scientific Excellence
We are relentless in our pursuit of scientific excellence and innovation. Our team of world-class researchers leverage the latest advances in plasmalogen biology, neuroscience and biotechnology. We are committed to rigorous research, data-driven evidence and upholding the highest ethical standards.
Determination to Persevere
Developing breakthrough treatments for complex neurological disorders and neurodegenerative diseases require determination and the courage to persevere through immense challenges. We embrace this journey with resilience, passion and an unwavering commitment to our mission.
Integrity and Accountability
Integrity is paramount in everything we do. We hold ourselves accountable to the highest principles of integrity, transparency and responsible conduct. Our stakeholders’ trust is sacred, and we strive to honor it every day.